Physician profile
James Cuellar
NPI 1912917998
$3,321.50
in general payments reported to CMS, 2019-2025
9 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $510 · 2021: $519 · 2022: $490 · 2023: $479 · 2024: $396 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,997.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $490.02 | 2021-2024 | Mounjaro, Trulicity, Zepbound |
| Eisai INC. | $311.51 | 2020-2021 | |
| Glaxosmithkline, LLC. | $161.82 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $127.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.53 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $63.77 | 2019 | |
| Medacta USA, INC. | $33.08 | 2019 | |
| Abbvie INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cuellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.